Graham Lappin

2.1k total citations
45 papers, 1.5k citations indexed

About

Graham Lappin is a scholar working on Pharmacology, Spectroscopy and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Graham Lappin has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 14 papers in Spectroscopy and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Graham Lappin's work include Pharmacogenetics and Drug Metabolism (24 papers), Analytical Chemistry and Chromatography (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Graham Lappin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (24 papers), Analytical Chemistry and Chromatography (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Graham Lappin collaborates with scholars based in United Kingdom, United States and Austria. Graham Lappin's co-authors include R. Colin Garner, Malcolm Rowland, B. Oosterhuis, Tal Burt, Lloyd Stevens, Robert J. Noveck, R. Jochemsen, J Kneer, W. J. Drijfhout and W. Kuhnz and has published in prestigious journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and Analytical Biochemistry.

In The Last Decade

Graham Lappin

45 papers receiving 1.4k citations

Peers

Graham Lappin

PHARM

ONCOL

SPECT

PPCH

Christopher R. Gibson United States

Handan He United States

Geert Mannens Belgium

Kimberly K. Adkison United States

Kevin B. Alton United States

Jane R. Kenny United States

Chuang Lu United States

Gian Camenisch Switzerland

Ulf G. Eriksson Sweden

Liang‐Shang Gan United States

Christopher R. Gibson United States

Graham Lappin

731 ×1.3

PHARM

418 ×1.1

558 ×1.6

ONCOL

185 ×0.6

SPECT

251 ×1.0

PPCH

Citations per year, relative to Graham Lappin Graham Lappin (= 1×) peers Christopher R. Gibson

Countries citing papers authored by Graham Lappin

Since Specialization

Citations

This map shows the geographic impact of Graham Lappin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Lappin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Lappin more than expected).

Fields of papers citing papers by Graham Lappin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Lappin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Lappin. The network helps show where Graham Lappin may publish in the future.

Co-authorship network of co-authors of Graham Lappin

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Lappin. A scholar is included among the top collaborators of Graham Lappin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Lappin. Graham Lappin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wagner, Cláudia, Markus Müller, Graham Lappin, & Oliver Langer. (2013). Positron emission tomography for use in microdosing studies. Figshare. 11 indexed citations

Lappin, Graham, Robert J. Noveck, & Tal Burt. (2013). Microdosing and drug development: past, present and future. Expert Opinion on Drug Metabolism & Toxicology. 9(7). 817–834. 67 indexed citations

Lappin, Graham, et al.. (2013). A microdose study of 14C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung. European Journal of Clinical Pharmacology. 69(9). 1673–1682. 13 indexed citations

Keely, Brendan J., et al.. (2012). Predicting Drug Candidate Victims of Drug-Drug Interactions, using Microdosing. Clinical Pharmacokinetics. 51(4). 237–246. 34 indexed citations

Duchateau, Guus, et al.. (2012). Absolute Oral Bioavailability and Metabolic Turnover of β-Sitosterol in Healthy Subjects. Drug Metabolism and Disposition. 40(10). 2026–2030. 32 indexed citations

Lappin, Graham, Yoko Shishikura, Roeline Jochemsen, et al.. (2011). Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers. European Journal of Pharmaceutical Sciences. 43(3). 141–150. 45 indexed citations

Lappin, Graham, Yoko Shishikura, Roeline Jochemsen, et al.. (2010). Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailability. European Journal of Pharmaceutical Sciences. 40(2). 125–131. 92 indexed citations

Madan, Ajay, Zhihong O’Brien, Chris O’Brien, et al.. (2009). A pharmacokinetic evaluation of five H₁ antagonists after an oral and intravenous microdose to human subjects. British Journal of Clinical Pharmacology. 67(3). 288–298. 40 indexed citations

Lappin, Graham & Lloyd Stevens. (2008). Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology. 4(8). 1021–1033. 58 indexed citations

10.

Lappin, Graham, W. Kuhnz, R. Jochemsen, et al.. (2006). Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs. Clinical Pharmacology & Therapeutics. 80(3). 203–215. 176 indexed citations

11.

Lappin, Graham, et al.. (2006). Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein. Journal of Pharmaceutical and Biomedical Analysis. 41(4). 1299–1302. 12 indexed citations

12.

Garner, R. Colin & Graham Lappin. (2006). Commentary. British Journal of Clinical Pharmacology. 61(4). 367–370. 61 indexed citations

13.

Lappin, Graham, Malcolm Rowland, & R. Colin Garner. (2006). The use of isotopes in the determination of absolute bioavailability of drugs in humans. Expert Opinion on Drug Metabolism & Toxicology. 2(3). 419–427. 63 indexed citations

14.

Lappin, Graham & R. Colin Garner. (2005). The use of accelerator mass spectrometry to obtain early human ADME/PK data. Expert Opinion on Drug Metabolism & Toxicology. 1(1). 23–31. 36 indexed citations

15.

Ravenzwaay, Bennard van, et al.. (2003). Comparative metabolism of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat and dog. Xenobiotica. 33(8). 805–821. 35 indexed citations

16.

Lappin, Graham & R. Colin Garner. (2003). Big physics, small doses: the use of AMS and PET in human microdosing of development drugs. Nature Reviews Drug Discovery. 2(3). 233–240. 188 indexed citations

17.

Lappin, Graham, et al.. (2003). Metabolism of methyl-(E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate (azoxystrobin) in rat. Xenobiotica. 33(6). 677–690. 9 indexed citations

18.

Lappin, Graham, et al.. (2002). Absorption, metabolism and excretion of 4-chloro-2-methylphenoxyacetic acid (MCPA) in rat and dog. Xenobiotica. 32(2). 153–163. 16 indexed citations

19.

Lappin, Graham, et al.. (1996). Metabolism of 2,3,5,6-tetrachloronitrobenzene (tecnazene) in rat. Xenobiotica. 26(1). 65–77. 2 indexed citations

20.

Provan, W. McLean, et al.. (1995). The incorporation of radiolabelled sulphur from captan into protein and its impact on a DNA binding study. Chemico-Biological Interactions. 96(2). 173–184. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact